Last checked at 28 Feb 2017 07:02
28 February 2017
Croda International Plc
Board Change
Dr Keith Layden to become a Non-Executive Director
Croda International Plc ('Croda' or 'the Company') today announces that Dr. Keith Layden, (57) Chief Technology Officer and President, Life Sciences, has decided to retire from the Company after 32 years of service. Keith has accepted the Board's invitation to continue as a Non-Executive Director and help guide Croda's highly successful innovation agenda further forward.
Dr. Nick Challoner, President, Asia, will also become President of Life Sciences and lead Croda's Global Research and Technology function.
These changes will take effect from 1 May 2017.
Anita Frew, Chairman, said:
"I would like to thank Keith for his long service and exceptional contribution to Croda. I am delighted that the Board will continue to have the benefit of Keith's unparalleled expertise in technology and innovation."
Steve Foots, Chief Executive Officer, said:
"Keith is one of the principal architects for Croda becoming the successful business that it is today. Under his direction, Croda has significantly expanded its R&D capability and introduced impactful new technologies to the market. I would like to thank him for over three decades of service and for being a huge inspiration to so many people at Croda and across our industry. We look forward to the enormous value that he will bring to Croda as a Non-Executive Director."
For enquiries contact:
Croda: Conleth Campbell, VP Investor Relations +44 1405 860551
Teneo Blue Rubicon: Charlie Armitstead +44 20 3603 5220